Equity (Details) - USD ($) $ in Thousands, shares in Millions |
1 Months Ended | 3 Months Ended | ||
---|---|---|---|---|
Aug. 11, 2023 |
Aug. 31, 2020 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Equity [Line Items] | ||||
Net proceeds | $ 14,695 | $ 770 | ||
Stock Options [Member] | ||||
Equity [Line Items] | ||||
Unrecognized compensation expense | $ 13,200 | |||
Weighted average term | 3 years 2 months 12 days | |||
Compensation expense | $ 1,200 | 800 | ||
Restricted Stock Units [Member] | ||||
Equity [Line Items] | ||||
Weighted average term | 1 year 4 months 24 days | |||
Compensation expense | $ 100 | $ 200 | ||
Fair value of RSU | $ 1,800 | |||
Vesting period | 3 years | |||
Unrecognized compensation | $ 800 | |||
Capital on Demand Sales Agreement [Member] | ||||
Equity [Line Items] | ||||
Aggregate value of common stock | $ 200,000 | |||
Shares of common stock (in Shares) | 1.8 | 0.1 | ||
Gross proceeds | $ 15,000 | $ 800 | ||
Net proceeds | $ 14,700 | $ 800 | ||
Common Stock [Member] | Warrant [Member] | ||||
Equity [Line Items] | ||||
Issuance and sale of stock | $ 500,000 | |||
Common Stock [Member] | Amended Sales Agreement [Member] | ||||
Equity [Line Items] | ||||
Aggregate value of common stock | $ 200,000 |
X | ||||||||||
- Definition Gross Proceeds. No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Value of preferred stock and warrants for common stock issued. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|